These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5800907)

  • 1. The frequency of isoniazid acetylase enzyme deficiency among Egyptians.
    Hashem N; Khalifa S; Nour A
    Am J Phys Anthropol; 1969 Jul; 31(1):97-101. PubMed ID: 5800907
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic variations in the acetylation of isoniazid and other drugs.
    Evans DA
    Ann N Y Acad Sci; 1968 Jul; 151(2):723-33. PubMed ID: 5263687
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigations into the polymorphism of acetylation of isonicotinic acid hydrazid (INH)].
    Goedde HW; Schloot W
    Med Welt; 1968 Dec; 51():2812-21. PubMed ID: 5752425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzymatic transformation of isonicotinic acid hydrazide--a pharmacogenetic problem].
    Goedde HW; Schloot W; Valesky A
    Arzneimittelforschung; 1966 Aug; 16(8):1030-4. PubMed ID: 4969359
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A slow-release preparation of isoniazid: pharmacological aspects.
    Ellard GA
    Bull Int Union Tuberc; 1976; 51(1):144-54. PubMed ID: 1030275
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of isoniazid metabolism in genetic studies. Anomalies encountered in trisomy 21 patients].
    Turpin R; Bergogne-Berezin E; Caille B; Salmon-Bonnereau D
    Ann Med Interne (Paris); 1969 Apr; 120(4):243-51. PubMed ID: 5356278
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
    Levi AJ; Sherlock S; Walker D
    Lancet; 1968 Jun; 1(7555):1275-9. PubMed ID: 4172137
    [No Abstract]   [Full Text] [Related]  

  • 10. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetical and geographic studies on isoniazid inactivation.
    SUNAHARA S; URANOM ; OGAWAM
    Science; 1961 Nov; 134(3489):1530-1. PubMed ID: 13918409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the isoniazid inactivation in Finns and Lapps.
    Tiitinen H; Mattila MJ; Eriksson AW
    Ann Med Intern Fenn; 1968; 57(4):161-6. PubMed ID: 5731346
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic determimants in drug action.
    La Du BN
    Adv Biol Skin; 1972; 12():95-109. PubMed ID: 4579210
    [No Abstract]   [Full Text] [Related]  

  • 14. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of isoniazid in urine and blood serum of nonhuman primates.
    Balk MW; Hughes HC; Lang CM
    J Am Vet Med Assoc; 1974 Apr; 164(7):728. PubMed ID: 4206400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic heterogeneity of hereditary enzymopathies].
    Krasnopol'skaia KD; Bochkov NP
    Vestn Akad Med Nauk SSSR; 1982; (9):56-64. PubMed ID: 7148122
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability study with a new isoniazid preparation.
    Eidus L; Hodgkin MM; Hsu AH
    Int J Clin Pharmacol; 1973 Oct; 8(2):154-9. PubMed ID: 4762906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic studies on the isoniazid (INH) therapy. 3. Decomposition of the INH derivatives and intestinal absorption].
    Okudaira M; Kuchii M; Shimizu Y
    Iryo; 1969 Dec; 23(12):1511-6. PubMed ID: 5382110
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of isoniazid and sulphadimidine in mongoloid subjects.
    Airaksinen E; Mattila MJ; Ollila O
    Ann Med Exp Biol Fenn; 1969; 47(4):303-7. PubMed ID: 4246038
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of sulphadimidine acetylation test in determining isoniazid inactivation rate in tuberculous patients.
    Sen PK; Chatterjee R; Saha JR
    Indian J Med Res; 1972 Jan; 60(1):28-39. PubMed ID: 5029122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.